Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Actions to Be Taken if Content Uniformity is Out of Specification

Posted on By

SOP for Actions to Be Taken if Content Uniformity is Out of Specification

Procedures for Addressing Content Uniformity Issues

1) Purpose

The purpose of this SOP is to outline the actions to be taken when content uniformity of capsules is found to be out of specification, including documentation and investigation procedures.

2) Scope

This SOP applies to all capsules produced within the pharmaceutical manufacturing facility that are found to have out-of-specification (OOS) content uniformity results.

3) Responsibilities

The Quality Control (QC) department is responsible for identifying content uniformity issues and implementing corrective actions. The Production department is responsible for addressing and documenting these issues.

See also  SOP for Blister Packaging Process

4) Procedure

  1. Identification of Content Uniformity Issues:
    1. During routine content uniformity tests, identify any capsules that fall outside the acceptable range.
    2. Document the non-conforming results in the content uniformity logbook.
  2. Immediate Actions:
    1. Isolate the affected batch or lot of capsules to prevent further processing or distribution.
    2. Notify the QC manager and relevant personnel about the content uniformity issue.
  3. Investigation:
    1. Conduct a thorough investigation to determine the root cause of the content uniformity issue.
    2. Review the manufacturing process, equipment calibration records, and operator logs for potential causes.
    3. Document the findings of the investigation in a deviation report.
  4. Corrective and Preventive Actions (CAPA):
    1. Develop and implement corrective actions to address the identified root cause.
    2. Implement
preventive actions to avoid recurrence of the content uniformity issue.
  • Verify the effectiveness of the corrective and preventive actions by re-testing a sample of capsules from the affected batch.
  • Documentation:
    1. Record all actions taken, including isolation, investigation, CAPA, and re-testing results, in the content uniformity logbook and deviation report.
    2. Update the batch record and quality control documents to reflect the resolution of the issue.
  • 5) Abbreviations, if any

    QC: Quality Control

    CAPA: Corrective and Preventive Actions

    6) Documents, if any

    Content Uniformity Logbook, Deviation Reports, Investigation Records, and CAPA Documentation

    7) Reference, if any

    Relevant regulatory guidelines such as ICH Q7 and FDA Guidance for Industry

    8) SOP Version

    Version 1.0

    See also  SOP for Procedures for Recording and Interpreting Disintegration Test Results
    Capsule Formulation Tags:Capsule Batch Record, Capsule Blending, Capsule Cleaning Validation, Capsule Coating, Capsule Deviation Investigation, Capsule Dosage Form, Capsule Encapsulation, Capsule Equipment Qualification, Capsule Filling, Capsule Formulation SOP, Capsule Inspection Procedure, Capsule Integrity, Capsule Manufacturing, Capsule Mixing, Capsule Polishing, Capsule Production, Capsule Quality Control, Capsule Sampling, Capsule Shell Inspection, Capsule Weight Check

    Post navigation

    Previous Post: Ointments: Ointments: SOP for Change Control Procedures in Ointment Formulation
    Next Post: Capsule Formulation: Capsule Formulation: SOP for Disintegration Testing

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version